Three cases of palmoplantar pustulosis successfully treated with apremilast
暂无分享,去创建一个
[1] L. French,et al. Successful treatment of SAPHO syndrome with apremilast , 2018, The British journal of dermatology.
[2] M. Gooderham,et al. Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.
[3] M. Kalavala,et al. Successful treatment of refractory palmoplantar pustulosis with apremilast , 2017, Clinical and experimental dermatology.
[4] T. Torres,et al. Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects , 2016, American Journal of Clinical Dermatology.
[5] E. Steingrímsson,et al. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo. , 2015, The Journal of investigative dermatology.
[6] M. Ramos‐e‐Silva,et al. Isomorphic phenomenon of Koebner: facts and controversies. , 2013, Clinics in dermatology.
[7] C. Massone,et al. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study , 2013, The British journal of dermatology.
[8] M. Picardo,et al. Clinical practice. Vitiligo. , 2009, The New England journal of medicine.
[9] R. Ogawa,et al. The Relationship Between Keloid Growth Pattern and Stretching Tension: Visual Analysis Using the Finite Element Method , 2008, Annals of plastic surgery.
[10] S. Lepreux,et al. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo , 2003, The British journal of dermatology.